A folate-receptor-targeted poly (lactide-co-Glycolide) (PLGA)-Polyethylene glycol (PEG) nanoparticle is developed for encapsulation and delivery of disulfiram into breast cancer cells. After a comprehensive characterization of nanoparticles, cell cytotoxicity, apoptosis induction, cellular uptake and intracellular level of reactive oxygen species are analyzed. In vivo acute and chronic toxicity of nanoparticles and their efficacy on inhibition of breast cancer tumor growth is studied. The folate-receptor-targeted nanoparticles are internalized into the cells, induce reactive oxygen species formation, induce apoptosis and inhibit cell proliferation more efficiently compared to the untargeted nanoparticles. The acute and toxicity test show the maximum dose of disulfiram equivalent of nanoparticles for intra-venous injection is 6 mg/kg while show significant decrease in the breast cancer tumor growth rate. It is believed that the developed formulation could be used as a potential vehicle for successful delivery of disulfiram, an old and inexpensive drug, into breast cancer cells and other solid tumors.

Many approaches have been developed to regenerate biological substitutes for repairing damaged tissues. Guided bone/tissue regeneration (GBR/GTR) that employs a barrier membrane has received much attention in recent years. Regardless of substantial efforts for treatment of damaged tissue in recent years, an effective therapeutic strategy is still a challenge for tissue engineering researchers. The aim of the current study is to fabricate a GBR membrane consisting of polycaprolactone (PCL)/gelatin/chitosan which is modified with different percentages of β-tricalcium phosphate (β-TCP) for improved biocompatibility, mechanical properties, and antibacterial activity. The membranes are examined for their mechanical properties, surface roughness, hydrophilicity, biodegradability and biological response. The mechanical properties, wettability and roughness of the membranes are improved with increases in β-TCP content. An increase in the elastic modulus of the substrates is obtained as the amount of β-TCP increases to 5% (145–200 MPa). After 5 h, the number of attached cells is enhanced by 30%, 40% and 50% on membranes having 1%, 3% and 5% β-TCP, respectively. The cell growth on a membrane with 3% of β-TCP is also 50% and 20% higher than those without β-TCP and 5% β-TCP, respectively. Expression of type I collagen is increased with addition of β-TCP by 3%, while there is no difference in ALP activity. The results indicated that a composite having (3%) β-TCP has a potential application for guided bone tissue regeneration.

The success of gene therapy is largely dependent on the development of a gene carrier. Recently cell-penetrating peptides (CPPs) have been employed for enhancing the gene and drug delivery efficacy of nano-particles. The feasibility of octaarginine (R8) functionalized graphene oxide (GO) as a novel nano-carrier for gene delivery is investigated. A DNA plasmid expressing enhanced green fluorescent protein (pEGFP) is used as a model gene to study the R8–GO transfection ability into mammalian cells. R8 peptide is conjugated in different ratios (0.1–1.5 μmol per mg of GO) to carboxylated graphene oxide by a two step amidation process. The process of peptide conjugation is analyzed by Fourier transform infrared (FTIR), atomic force microscopy (AFM), UV-vis spectroscopy and X-ray diffraction (XRD). In order to obtain the highest transfection of pEGFP into the cells, the amount of peptide bound to GO is optimized which is evidenced by dynamic light scattering (DLS), zeta potential, TNBS and gel retardation assays. The cytotoxicity of R8-functionalized GO is also tested by MTT assay. The results confirm the successful attachment of R8 peptide to GO. The AFM and XRD results show a significant increase in the thickness of nano graphene oxide sheets (NGOS) from 0.8 to 2–7 nm as well as an increase in the GO interlying space after the R8-functionalization process. A reduction in nano-carrier stability in both aqueous solution and cell culture media is observed when the amount of peptide is increased to more than 1 μmol mg⁻¹. Gel electrophoresis analysis shows the highest DNA loading on the peptide functionalized GO at the ratios of 0.5 and 1 μmol mg⁻¹. As a result, the conjugated peptide sample with a peptide molar ratio of 1 μmol per mg of GO shows the highest conjugational efficiency and EGFP gene expression along with improved dispersibility and biocompatibility. Overall, the findings reveal the importance of peptide density on the surface of NGOS in order to obtain the most efficient cell transfection. It is concluded that the R8-conjugated GO could be a promising nano-carrier for gene delivery with relevance in biotechnology therapeutics and clinical applications.

Hydrogels have found many practical uses in drug release, wound dressing, and tissue engineering. However, their applications are restricted due to their weak mechanical properties. The role of graphene oxide nanosheets (GONS) as reinforcement agent in poly (acrylic acid) (PAA)/Gelatin (Gel) composite hydrogels is investigated. Composite hydrogels are synthesized by thermal initiated redox polymerization method. Samples are then prepared with 20 and 40 wt. % of PAA, an increasing amount of GONS (0.1, 0.2, and 0.3 wt. %), and a constant amount of Gel. Subsequently, cylindrical hydrogel samples are subjected to a series of compression tests in order to measure their elastic modulus, maximum stress and strain. The results exhibit that the addition of GONS increases the Young's modulus and maximum stress of hydrogels significantly as compared with control (0.0 wt. % GONS). The highest Young's modulus is observed for hydrogel with GO (0.2 wt. %)/PAA (20 wt. %), whereas the highest maximum stress is detected for GO (0.2 wt. %)/PAA (40 wt. %) specimen. The addition of higher amounts of GONS leads to a decrease in the maximum stress of the hydrogel GO (0.3 wt. %)/PAA (40 wt. %). No significant differences are detected for the maximum strain among the hydrogel samples, as the amount of GONS increased. These results suggest that the application of GONS could be used to improve mechanical properties of hydrogel materials. This study may provide an alternative for the fabrication of low-cost graphene/polymer composites with enhanced mechanical properties beneficial for tissue engineering applications.

Atherosclerosis is a disease in which plaque builds up inside arteries. It is also considered as one of the most serious and common forms of cardiovascular disease which can lead to heart attack and stroke. In the current research, finite element method is used to anticipate plaque vulnerability based on peak plaque stress using human samples. A total of 23 healthy and atherosclerotic human coronary arteries, including 14 healthy and 9 atherosclerotic are removed within 5 h postmortem. The samples are mounted on a uniaxial tensile test machine and the obtained mechanical properties are used in finite element models. The results, including the Mooney–Rivlin hyperelastic constants of the samples as well as peak plaque stresses, are computed. It is demonstrated that the atherosclerotic human coronary arteries have significantly (p < 0.05) higher stiffness compared to healthy ones. The hypocellular plaque, in addition, has the highest stress values compared to the cellular and calcified ones and, consequently...